Receptor binding studies were undertaken in an attempt to identify and characterize pharmacologically and functionally distinct receptor sites for y-aminobutyric acid (GABA) in rat brain. The results indicated that the potency of bicuculline, a GABA receptor antagonist, to displace membranebound [3H]GABA varies significantly among different brain regions, with the greatest potency found in the cerebral cortex and midbrain. In addition, in the presence of 50 mM ammonium thiocyanate,
It has been estimated that y-aminobutyric acid (GABA) is the neurotransmitter for up to 40% of the neurons in the mammalian central nervous system (Bloom and Iversen, 1971) . In light of this ubiquity, it is somewhat surprising that, unlike the catecholamines and acetylcholine, there is, as yet, little direct evidence to support the existence of pharmacologically and functionally distinct subsets of synaptic receptor sites for this amino acid in brain (Enna, 1981a, b) . Electrophysiological and biochemical experiments have indicated that there may be a class of bicuculline-insensitive GABA receptors (Curtis and Felix, 1971; Krnjevic, 1974; Bowery et al., 1980) to characterize these sites further, it is impossible to define their biological significance. In addition, receptor ligand binding studies have identified at least two kinetically distinct binding sites for GABA in brain tissue, although their pharmacology appears to be quite similar if not identical (Enna and Snyder, 1977) .
More recently, reports have indicated that GABA receptors are functionally linked to benzodiazepine binding sites in brain (Tallman et al., 1978; Maggi et al., 1980) . These experiments have revealed that, in vitro, activation of GABA receptors induces a shift in the affinity of the benzodiazepine binding site, with increasing concentrations of GABA inducing an increase in the amount of bound radiolabeled benzodiazepine.
As a result of these findings, a number of laboratories have explored the relationship between benzodiazepine and GABA receptors. Both biochemical and autoradiographic studies suggest that, in fact, not all GABA receptors are linked to the benzodiazepine binding site (Young and Kuhar, 1979; Palacios et al., 1979) , indicating some degree of functional specificity for GABA receptors.
In the present study, experiments were undertaken to characterize further the biochemical, pharmacological, Previous work had indicated that 50 mM ampended in buffer and centrifuged two more times prior to monium thiocyanate and other chaotropic agents inthe preparation of a final aqueous suspension of the crease the potency of bicuculline to displace [3H]GABA membranes, which contained 0.5 to 1 mg of protein/ml. from rat brain membranes without appreciably altering For the receptor binding assay, 1 ml portions of this the affinity of the receptor for GABA itself (Enna and membrane suspension were added to tubes containing 1 Snyder, 1977) . It is noteworthy, however, that in this ml of 0.1 M buffer plus ["HI-y-aminobutyric acid earlier study, the brain membranes had not been treated (["HIGABA; 57 Ci/mmol) in the presence and absence of with Triton X-100. To determine whether there was any various concentrations of unlabeled GABA or bicuculregional specificity for this phenomenon with Tritonline, a GABA receptor antagonist. The mixture was intreated tissue, the potency of bicuculline to inhibit ["HIcubated, the reaction was terminated by centrifugation, GABA binding in the presence of 50 mM ammonium and the tissue was analyzed as previously described thiocyanate was examined in various brain regions (Table  (Enna and Snyder, 1977) . Total specific receptor binding I). The results indicated that ammonium thiocyanate was defined as the amount of [3H]GABA displaced by lo-" M unlabeled GABA. The concentration of [3H]-causes markedly different shifts in the potency of bicuculline in the brain regions studied, with the potency of GABA in the incubation medium was 4 nM.
bicuculline increasing almost loo-fold in the midbrain In some experiments, receptor binding was assayed in but only lo-fold in the cerebellum. Intermediate shifts the presence of 50 mM ammonium thiocyanate (SCN). In this case, the buffer in the assay tubes contained 100 mM SCN prior to the addition of tissue homogenate. lished procedure (Maggi et al., 1980 were noted in the cerebral cortex (63-fold) and corpus striatum (25fold) ( Table I) . Interestingly, the potency of bicuculline to displace receptor-bound ["HIGABA differs among the various brain regions even in the absence of ammonium thiocyanate, with the I&o for bicuculline in the corpus striatum and cerebellum being over 3 times greater than that found in the midbrain and cerebral cortex. This suggests that the cortical and midbrain GABA receptors have a greater affinity for bicuculline than the receptors labeled in the corpus striatum and cerebellum (Table I) . Furthermore, the differences between these brain regions is magnified in the presence of ammonium thiocyanate.
Thus, bicuculline was lo-to 20-fold weaker in the corpus striatum and cerebellum than in the midbrain and cerebral cortex even in the presence of the chaotropic agent.
Influence of ammonium thiocyanate on GABA receptor function. To determine whether the ammonium thiocyanate-induced increase in the potency of bicuculline had any functional significance, the ability of this alkaloid to inhibit GABA-activated benzodiazepine receptor binding was examined in the presence and absence of the salt (Table II) . As seen with the GABA receptor binding assay, bicuculline was significantly weaker in inhibiting GABA-activated
[3H]diazepam binding in the cerebellum as compared to the cerebral cortex. Similarly, when the assay was performed in the presence of ammonium thiocyanate, the potency of bicuculline to inhibit GABAactivated benzodiazepine receptor binding was increased significantly in both brain regions, being enhanced about 30-fold in the cerebral cortex and about lo-fold in cerebellar membranes (Table II) . Ammonium thiocyanate also increased the difference in the potency of bicuculline in the two brain regions to inhibit the GABA receptormediated change in [3H]diazepam binding. Thus, in the absence of the salt, the I& for bicuculline was some 2-fold greater (lower affinity) in the cerebellum than in the cerebral cortex, whereas in the presence of thiocyanate, the difference was almost lo-fold (Table II) .
The influence of ammonium thiocyanate on GABA and benzodiazepine receptor binding. In addition to altering the potency of bicuculline to displace ['HIGABA binding, 50 mM ammonium thiocyanate significantly reduced the amount of GABA bound to rat brain membranes (Table III) . When the assay medium contained the salt, specifically bound ["HIGABA was reduced by 34% in the cerebral cortex and over 25% in the cerebellum. Nonspecific binding was not significantly influenced by this treatment. In addition, neither basal [3H]diazepam binding nor GABA-activated ["Hldiazepam binding was altered significantly in the presence of ammonium thiocyanate (Table III) .
To determine the reason for the reduction in specifically bound [3H]GABA binding, GABA receptor saturation analysis was performed in the presence and absence of the salt (Table IV ). In the absence of ammonium thiocyanate, a two-component saturation curve was detected, indicating the presence of high affinity (Kd = 33 nM) and low affinity (Kd = 110 nM) binding sites for this amino acid. However, in the presence of 50 mM ammonium thiocyanate, only a single [3H]GABA receptor bind- ing site was detected, with an affinity (96 nM) and concentration (2.8 pmol/mg of protein) virtually identical to that observed for the low affinity site noted in the absence of ammonium thiocyanate (Table IV While ammonium thiocyanate did not alter the increase in [3H]diazepam binding induced by a saturating concentration of GABA (Table III) , it is conceivable that this treatment affected the potency of GABA to initiate this response. To test this, [3H]diazepam binding was determined in the presence of various concentrations of unlabeled GABA, with and without ammonium thiocyanate (Table V) . Incubation with 50 mM ammonium thiocyanate did not alter the potency of GABA to activate benzodiazepine binding in either the cerebral cortex or cerebellum, suggesting that the activation phenomenon is unaffected by treatment with this chaotropic agent.
Discussion
The results of the present investigation lend further evidence to support the existence of multiple GABA binding sites. These data indicate that not only are there different classes of GABA receptor binding sites based on differing affinities for bicuculline, but also that the high and low affinity GABA receptor sites differ with regard to function. This was suggested by the results obtained with ammonium thiocyanate which indicated that the low, but not the high, affinity GABA receptor binding site is coupled to the benzodiazepine receptor site.
The finding that bicuculline is significantly more potent in displacing [3H]GABA from midbrain and cerebral cortical tissue than from corpus striatum and cerebellum was somewhat surprising in light of a previous study reporting no significant differences in the potency of this alkaloid to displace GABA from various human brain regions (Enna et al., 1979) . A possible explanation for this discrepancy is that, in the present study, the entire cerebral cortex, midbrain, and cerebellum were utilized for assay, whereas in the human study, only select areas of these brain regions were examined. On the other hand, the differences may be related primarily to the differ- 0.63 + 0.08 0.36 + 0.14 0.32 + 0.14 ences in the species examined. In any event, the present findings suggest that the GABA receptor affinity for bicuculline differs among certain rat brain regions, suggesting the presence of pharmacologically distinct GABA receptor subtypes. Such a conclusion would be in accord with previous data indicating a greater amount of ["HIbicuculline binding in rat cerebral cortex than in cerebellum (Mohler and Okada, 1977) . Although the opposite is true for GABA receptor binding (Enna and Snyder, 1975) , electrophysiological studies have suggested the existence of GABA receptors that are less sensitive to bicuculline (Curtis and Felix, 1971; Krnjevic, 1974) . Further evidence for multiple GABA binding sites was provided by the results obtained using ammonium thiocyanate, a chaotropic agent. Previous studies have indicated that, using tissue not previously treated with Triton X-100, the ammonium or sodium salts of thiocyanate, iodide, and nitrate increase the potency of bicuculline to displace membrane-bound [3H]GABA without appreciably altering the affinity of GABA for the receptor site (Enna and Snyder, 1977) . In the present study, it was found that a similar effect can be observed in Tritontreated tissue and the finding that the degree of enhancement in the potency of bicuculline differs among the brain regions examined supports the contention that there are fundamental differences in the physiocochemical properties of GABA receptors.
Since chaotropic agents like thiocyanate are useful for solubilizing particulate proteins (Hatefi and Hanstein, 1969) , it is possible that the shift in the potency of bicuculline may be due to the removal of some endogenous material which modifies the affinity of the receptor for the alkaloid. If this is the case, the differential effect of ammonium thiocyanate in the brain regions examined may be related to the relative concentrations of this endogenous material. Such a contention is supported by the correlation between the potency of bicuculhne to inhibit specifically bound [3H]GABA in various brain areas and the magnitude of the shift of these potencies in the presence of ammonium thiocyanate (Table I) . That is, in untreated membranes, the affinity would be higher because there may be less endogenous substance in the cortical and midbrain regions. After treatment with ammonium thiocyanate, most, or all, of the substance is removed in those areas having less of the endogenous material, whereas this concentration of thiocyanate is insufficient to rid other tissues, like the corpus striatum and cerebellum, of this material. To test this, the potency of bicuculline to inhibit [3H]GABA binding in cerebullar membranes was tested over a wide range of ammonium thiocyanate concentrations (up to 200 mM). The IC50 in the cerebellum appeared to approach that observed in the cerebral cortex when exposed to higher concentrations of salt (data not shown). However, these data were inconclusive because, with increasing concentrations of thiocyanate, the amount of specifically bound [3H]GABA also decreased, making it difficult to obtain consistent and conclusive data. It is unlikely that this hypothetical substance is GABA itself since removal would be expected to significantly affect the IC& for GABA as well as bicuculline, which is not the case. Nevertheless, the possibility must be considered 518 Browner et al. Vol. 1, No. 5, May 1981 that the apparent differences in GABA receptors with respect to bicuculline may be due to the presence, at or near the GABA receptor, of some thiocyanate-sensitive substance rather than, or in addition to, a fundamental difference in the physicochemical properties of the receptor molecule. Using GABA-activated benzodiazepine binding as a biochemical measure of GABA receptor function, the present results also indicate that the thiocyanate-induced shift in the potency of bicuculline is functionally significant in that thiocyanate increased the potency of bicuculline to inhibit the GABA receptor-mediated activation of benzodiazepine binding. Even more significant, however, was the finding that ammonium thiocyanate completely abolished the high affinity binding site for GABA, leaving the low affinity site and the GABA-activated benzodiazepine binding unaltered. While the precise reason for this phenomenon is unknown, it would seem most likely that, at this concentration, ammonium thiocyanate is able to solubilize the high affinity site for GABA selectively. It is unclear at this time whether this action and the effect on the potency of bicuculline are related. Nevertheless, this finding directly demonstrates that the high and low affinity binding sites for GABA are functionally different in that the low, but not the high, is linked to the benzodiazepine receptor. Such a conclusion supports the work of others where, using less direct methods, it has been hypothesized that only the low affinity GABA binding site is associated with the benzodiazepine receptor (Palacios et al., 1979; Braestrup et al., 1980) .
In conclusion, the present findings point to the existence of pharmacologically and functionally distinct GABA receptors in brain. The discovery that only low affinity GABA receptors are linked to the benzodiazepine binding site lends biochemical support to the autoradiographic evidence that not all GABA receptors are linked to the binding sites for this drug. The discovery that ammonium thiocyanate selectively abolishes high affinity GABA binding may provide new insights with regard to solubilizing this site and may be a useful method for identifying and defining pharmacologically and functionally distinct GABA receptors in brain.
